Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Apple
AAPL
|
+$564M |
| 3 |
Amazon
AMZN
|
+$486M |
| 4 |
Meta Platforms (Facebook)
META
|
+$331M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$1.88B |
| 2 |
Alibaba
BABA
|
+$1.21B |
| 3 |
Home Depot
HD
|
+$320M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$274M |
| 5 |
FLIR
FLIR Systems, Inc. (DE) Common Stock
FLIR
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.98% |
| 2 | Financials | 13.87% |
| 3 | Healthcare | 13.39% |
| 4 | Consumer Discretionary | 11.81% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCS
2851
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $5.39M | ﹤0.01% |
27,541
+231
| +0.8% | +$48K |
|
2852
Neurogene
NGNE
$656M
| $5.38M | ﹤0.01% |
29,131
+2,269
| +8% | +$502K |
|
2853
GT Biopharma
GTBP
$11.1M
| $5.37M | ﹤0.01% |
11,554
+7,208
| +166% | +$3M |
|
|
MTEM
2854
DELISTED
Molecular Templates, Inc.
MTEM
| $5.36M | ﹤0.01% |
45,736
+8,105
| +22% | +$1.06M |
|
2855
First Internet Bancorp
INBK
$261M
| $5.36M | ﹤0.01% |
173,130
+3,270
| +2% | +$111K |
|
2856
Rekor Systems
REKR
$90M
| $5.36M | ﹤0.01% |
527,906
+274,225
| +108% | +$4.2M |
|
2857
Viant Technology
DSP
$245M
| $5.36M | ﹤0.01% |
180,000
+14,067
| +8% | +$452K |
|
|
STFC
2858
DELISTED
State Auto Financial Corp
STFC
| $5.34M | ﹤0.01% |
312,056
+13,095
| +4% | +$245K |
|
2859
Pure Cycle
PCYO
$258M
| $5.34M | ﹤0.01% |
386,509
+2,234
| +0.6% | +$31.9K |
|
|
QTNT
2860
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $5.34M | ﹤0.01% |
36,673
+1,884
| +5% | +$301K |
|
2861
Intrepid Potash
IPI
$447M
| $5.32M | ﹤0.01% |
166,841
+4,134
| +3% | +$122K |
|
2862
SIGA Technologies
SIGA
$230M
| $5.28M | ﹤0.01% |
841,216
-33,302
| -4% | -$229K |
|
2863
Altimmune
ALT
$583M
| $5.27M | ﹤0.01% |
535,516
+286,386
| +115% | +$3.92M |
|
2864
KRONOS Worldwide
KRO
$708M
| $5.27M | ﹤0.01% |
368,115
+8,489
| +2% | +$138K |
|
|
SYRS
2865
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $5.27M | ﹤0.01% |
96,645
+13,344
| +16% | +$790K |
|
2866
Aviat Networks
AVNW
$265M
| $5.26M | ﹤0.01% |
160,531
+76,709
| +92% | +$2.67M |
|
2867
ClearPoint Neuro
CLPT
$461M
| $5.25M | ﹤0.01% |
275,291
+159,353
| +137% | +$3.08M |
|
2868
Cytosorbents Corp
CTSO
$23.1M
| $5.24M | ﹤0.01% |
693,833
+36,374
| +6% | +$306K |
|
2869
AgEagle Aerial Systems
UAVS
$42.1M
| $5.23M | ﹤0.01% |
993
+590
| +146% | +$3.24M |
|
|
ONTF
2870
DELISTED
ON24
ONTF
| $5.22M | ﹤0.01% |
147,233
+11,891
| +9% | +$465K |
|
2871
United States Lime & Minerals
USLM
$3.21B
| $5.22M | ﹤0.01% |
187,625
+19,990
| +12% | +$562K |
|
|
EMKR
2872
DELISTED
Emcore Corp
EMKR
| $5.22M | ﹤0.01% |
56,583
+31,819
| +128% | +$2.57M |
|
2873
Aligos Therapeutics
ALGS
$28.5M
| $5.21M | ﹤0.01% |
10,214
+3,064
| +43% | +$1.95M |
|
|
TBHC
2874
DELISTED
The Brand House Collective
TBHC
| $5.2M | ﹤0.01% |
227,244
+108,818
| +92% | +$2.92M |
|
2875
Ezcorp Inc
EZPW
$1.86B
| $5.19M | ﹤0.01% |
861,026
+46,049
| +6% | +$291K |
|
Similar funds
Geode Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
- Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
- Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
- Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
- Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
- Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.
Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.